Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guilin Huiang Biochemistry Pharmaceutical
Guilin, Guangxi Zhuang Autonomous Region, Chinaen.guilinpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Guilin Huiang Biochemistry Pharmaceutical is the largest manufacturer of paclitaxel active pharmaceutical ingredient (API) in China, with an annual output of 400 kg. The company produces both natural and semi-synthetic forms of paclitaxel for use in oncology therapeutics. It holds regulatory filings such as USDMF and CEP/COS for its APIs.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeNatural product (Paclitaxel)Semi-synthetic small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Guilin Huiang Biochemistry Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guilin Huiang Biochemistry Pharmaceutical.